InvestSMART

Antisense Therapeutics Limited (ASX: ANP) - Announcements

Current share price for ANP : $0.058 0.003 (4.92%)+

ASX company news and announcements for Antisense Therapeutics Limited (ANP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Antisense Therapeutics Limited (ANP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Antisense Therapeutics Limited (ANP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Antisense Therapeutics Limited (ANP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$52 Antisense Therapeutics to enter clincial development in DMD 26 Jun 2017 10:11AM $0.033 $0.058 risen by 75.76%
$52 ATL1102 for MS Phase IIb IND submitted to the FDA 26 Jun 2017 10:00AM $0.033 $0.058 risen by 75.76%
$52 Positive effects with ATL1102 on MS Black Hole lesions 16 Jun 2017 9:08AM $0.025 $0.058 risen by 132%
$52 ATL1103 Update 18 May 2017 9:06AM $0.032 $0.058 risen by 81.25%
$52 Appendix 4C - quarterly 27 Apr 2017 9:15AM $0.034 $0.058 risen by 70.59%
$52 ATL1102 for MS Phase IIb Investigational New Drug Submission 24 Apr 2017 8:59AM $0.033 $0.058 risen by 75.76%
$52 Market and Technology Update 24 Mar 2017 9:21AM $0.033 $0.058 risen by 75.76%
$52 Change of Director's Interest Notice (RM) 1 Mar 2017 8:44AM $0.039 $0.058 risen by 48.72%
$52 ATL1103 Patent Update 24 Feb 2017 8:23AM $0.035 $0.058 risen by 65.71%
$52 Half Year Accounts 24 Feb 2017 8:11AM $0.035 $0.058 risen by 65.71%
$52 Proposed International Nonproprietary Name for ATL1103 23 Feb 2017 9:15AM $0.039 $0.058 risen by 48.72%
$52 ATL1102 for MS - Progress Update 16 Feb 2017 9:42AM $0.041 $0.058 risen by 41.46%
$52 Change of Director's Interest Notice (RM, MD) 13 Feb 2017 9:21AM $0.041 $0.058 risen by 41.46%
$52 Completion of Less Than Marketable Parcel Share Sale Program 8 Feb 2017 10:31AM $0.037 $0.058 risen by 56.76%
$52 Appendix 4C - quarterly 30 Jan 2017 9:15AM $0.038 $0.058 risen by 52.63%
$52 Final Trading Day for ANPO Listed Options 19 Jan 2017 8:57AM $0.042 $0.058 risen by 38.10%
$52 Expiry of ANPO Listing Options 16 Jan 2017 11:58AM $0.044 $0.058 risen by 31.82%
$52 Change of Director's Interest Notice (RM) 9 Jan 2017 12:00AM $0.055 $0.058 risen by 5.45%
$52 Corporate Presentation 4 Jan 2017 8:59AM $0.035 $0.058 risen by 65.71%
$52 Change of Director's Interest Notice - (RM, MD, GM, WG) 21 Dec 2016 4:24PM $0.037 $0.058 risen by 56.76%
$52 Appendix 3B - Issue of Securities 20 Dec 2016 5:42PM $0.037 $0.058 risen by 56.76%
$52 Results of Rights and Bonus Issue 20 Dec 2016 12:49AM $0.037 $0.058 risen by 56.76%
$52 Appendix 3C 8 Dec 2016 8:51AM $0.036 $0.058 risen by 61.11%
$52 Change of Director's Interest Notice (RM) 5 Dec 2016 9:02AM $0.041 $0.058 risen by 41.46%
$52 Appendix 3B 29 Nov 2016 9:38AM $0.041 $0.058 risen by 41.46%

376 - 400 of 707 results

Page 16 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.